Acer Therapeutics Inc (NASDAQ:ACER)
| 4.96 Delayed Data As of Aug 11 |  -0.13 / -2.55%Today’s Change | 1.08 Today|||52-Week Range 7.25 | +23.69% Year-to-Date |
Latest ACER News | Press Releases
No recent news for Acer Therapeutics Inc.
Today’s Trading
| Previous close | 5.09 |
| Today’s open | 4.97 |
| Day’s range | 4.79 - 5.40 |
| Volume | 11,554 |
| Average volume (3 months) | 318,140 |
| Market cap | $55.3M |
Data as of 3:59pm ET, 08/11/2020
Growth & Valuation
| Earnings growth (last year) | -17.18% |
| Earnings growth (this year) | +53.06% |
| Earnings growth (next 5 years) | +10.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CPIXCumberland Pharmaceu... | -0.01 | -0.29% |
| SNSSSunesis Pharmaceutic... | -0.00 | -0.58% |
| APDNApplied DNA Sciences... | +0.02 | +0.20% |
| ALRNAileron Therapeutics... | +0.03 | +2.42% |
Data as of 4:50pm ET, 08/11/2020
Financials
| Next reporting date | August 18, 2020 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$29.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newton, Massachusetts |
Forecasts
